Uncategorized
Teva Pharmaceuticals Fails to Disqualify Jazz Pharmaceuticals’ Epidyolex Patent In Court
Jazz Pharmaceuticals has rebuffed attempts by rival Teva Pharmaceuticals to legally disqualify its patent for Epidyolex, a cannabis-based drug worth
Ben Stevens
January 16, 2024
